How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Virus Preservation Solution Market
- By Product Type: Cryopreservation Solutions, Liquid Preservation Solutions, Freeze-Drying Preservation Solutions, Chemical Preservation Solutions
- By Virus Type: DNA Viruses, RNA Viruses, Retroviruses, Bacteriophages
- By End User: Research Laboratories, Pharmaceutical Companies, Diagnostic Laboratories, Biotechnology Companies, Academic and Research Institutes
- By Preservation Method: Cryogenic Storage, Refrigerated Storage, Freeze-Drying (Lyophilization)
- By Application: Vaccine Development, Diagnostic Testing, Gene Therapy Research, Viral Vector Storage
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cryopreservation Solutions leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Virus Preservation Solution Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Virus Type 4
End User 5
Preservation Method 3
Application 4
Companies profiled
Thermo Fisher Scientific
Merck KGaA (MilliporeSigma)
Lonza Group AG
Corning Incorporated
Sigma-Aldrich Corporation
VWR International (Avantor)
BD (Becton
Dickinson and Company)
Greiner Bio-One International GmbH
Nalgene (Thermo Fisher Scientific)
CryoLife Inc.
BioLife Solutions Inc.
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Lonza Group AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Corning Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sigma-Aldrich Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →VWR International (Avantor)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →BD (Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Dickinson and Company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Greiner Bio-One International GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Nalgene (Thermo Fisher Scientific)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →CryoLife Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →BioLife Solutions Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Asahi Kasei Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Nippon Genetics Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Sartorius AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Cryoport
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,830M by 2033 · 9.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cryopreservation Solutions38.8
- Liquid Preservation Solutions20.1
- Freeze-Drying Preservation Solutions13.7
- Chemical Preservation Solutions27.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$911.2M → $2,120M · 11.1%
Europe$635.1M → $1,419M · 10.6%
Asia Pacific$579.9M → $1,111M · 8.5%
Latin America$359.0M → $821.9M · 10.9%
Middle East and Africa$276.1M → $558.1M · 9.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.752026
9.752027
9.772028
9.782029
9.782030
9.812031
9.822032
9.842033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific20.6
- Merck KGaA (MilliporeSigma)18.2
- Lonza Group AG4.6
- Corning Incorporated7.1
- Sigma-Aldrich Corporation11.3
- VWR International (Avantor)10.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type19.3%
Virus Type31.3%
End User18.4%
Preservation Method20.3%
Application10.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.2
- Europe23.5
- Asia Pacific18.4
- Latin America13.6
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 94 | 82 | 86 | 89 | 79 | 93 | 87 |
| Merck KGaA (MilliporeSigma) | 84 | 83 | 90 | 86 | 68 | 91 | 84 |
| Lonza Group AG | 88 | 64 | 77 | 77 | 79 | 75 | 77 |
| Corning Incorporated | 67 | 79 | 82 | 81 | 69 | 63 | 74 |
| Sigma-Aldrich Corporation | 59 | 57 | 53 | 68 | 67 | 75 | 63 |
| VWR International (Avantor) | 67 | 54 | 69 | 46 | 51 | 64 | 59 |
| BD (Becton | 55 | 50 | 49 | 62 | 65 | 45 | 54 |
| Dickinson and Company) | 35 | 58 | 44 | 60 | 43 | 42 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Merck KGaA (MilliporeSigma)
- Lonza Group AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Merck KGaA (MilliporeSigma) | ✓ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Lonza Group AG | ✓ | − | ✓ | ◐ | ◐ | ◐ |
| Corning Incorporated | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Sigma-Aldrich Corporation | ◐ | − | − | ◐ | ◐ | ◐ |
| VWR International (Avantor) | − | − | ◐ | − | − | ◐ |
| BD (Becton | − | − | − | ◐ | ◐ | ◐ |
| Dickinson and Company) | − | ◐ | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific87
2Merck KGaA (MilliporeSigma)84
3Lonza Group AG77
4Corning Incorporated74
5Sigma-Aldrich Corporation63
6VWR International (Avantor)59
7BD (Becton54
8Dickinson and Company)47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificMerck KGaA (MilliporeSigma)
Challenger2
Strong scale, closing on the leaders.
Lonza Group AGCorning Incorporated
Contender2
Focused players with pockets of strength.
Sigma-Aldrich CorporationVWR International (Avantor)
Niche2
Specialists in a single segment or region.
BD (BectonDickinson and Company)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Virus Preservation Solution Market — a $797M beachhead inside a $10.3B market.
Beachhead (SOM)$797Mobtainable near-term
Serviceable (SAM)$4.21Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Cryopreservation Solutions
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
Liquid Preservation Solutions
Strong fit — clear ROI and a fast path to value.
End user67 fit
Freeze-Drying Preservation Solutions
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Virus Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Virus Preservation Solution Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified24%
Evaluation14%
Closed-won8%
$9.9KCAC
$40KLTV
4.1:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Virus Preservation Solution Market is a durable-growth opportunity — $3.69B by 2033, compounding at 9.5%.
TAM · 2025$1.79Btoday
TAM · 2033$3.69Bforecast
CAGR9.5%2027–2033
Cumulative$23.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.69BTotal addressable market
SAM$1.41BServiceable available market
SOM$227MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.69BLarge & growingTAM by 2033 at 9.5% CAGR
$1.41BServiceable nowreachable with today’s model
$227MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.88BBear6.1% CAGR
$3.69BBase9.5% CAGR
$4.73BBull12.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Virus Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Virus Preservation Solution Market — a $5.55B market by 2033. Plan: grow share from 6.4% to 11.1%.
Market size · 2033$5.55Btotal addressable
Market CAGR4.3%2027–2033
Target share11.1%from 6.4% today
Revenue ambition$616Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.4% | 11.1% | On track |
| Revenue | $326M | $616M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 32.2% | 38.5% | At risk |
| Customer retention | 89.2% | 95.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Virus Type capability
A defensible second engine — invest in Virus Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Virus Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $73M capacity & capability investment
- Greenlight bolt-on M&A in Virus Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Virus Preservation Solution Market conversation — a $6.24B market you can size, segment and defend in minutes.
Market size · 2033$6.24Btotal opportunity
Growth3.2%CAGR to 2033
Addressable buyers1,042+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 3 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Thermo Fisher ScientificMerck KGaA (MilliporeSigma)Lonza Group AGCorning IncorporatedSigma-Aldrich CorporationVWR International (Avantor)BD (BectonDickinson and Company)+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Virus Preservation Solution Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Virus Preservation Solution Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Virus Preparation Services Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportVirus Nucleic Acid Isolation Kit Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportVirus-like Particle (VLP) Service Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportVirus-like Particles (VLPs) Vaccine Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportVirus-like Particle Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportVirus-Induced Asthma Treatment Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportVirus Filtration Solutions Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportVirus Filtration Membrane Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportVirus DNA Extraction Kit Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportVirus DNA and RNA Extraction Kit Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportVirus Diagnostics Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportVirus Cryopreservation Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.